KR101884330B1 - Helth functional food comprising the extract of deer antlers having the effect on stress and calmness - Google Patents
Helth functional food comprising the extract of deer antlers having the effect on stress and calmness Download PDFInfo
- Publication number
- KR101884330B1 KR101884330B1 KR1020160126959A KR20160126959A KR101884330B1 KR 101884330 B1 KR101884330 B1 KR 101884330B1 KR 1020160126959 A KR1020160126959 A KR 1020160126959A KR 20160126959 A KR20160126959 A KR 20160126959A KR 101884330 B1 KR101884330 B1 KR 101884330B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- functional food
- present
- stress
- Prior art date
Links
- 235000013376 functional food Nutrition 0.000 title abstract description 33
- 210000003056 antler Anatomy 0.000 title description 21
- 239000000284 extract Substances 0.000 title description 20
- 241000282994 Cervidae Species 0.000 title description 2
- 230000001814 effect on stress Effects 0.000 title description 2
- 239000000843 powder Substances 0.000 claims description 18
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 9
- 244000269722 Thea sinensis Species 0.000 claims description 9
- 229940010454 licorice Drugs 0.000 claims description 9
- 235000005687 corn oil Nutrition 0.000 claims description 6
- 239000002285 corn oil Substances 0.000 claims description 6
- 235000009569 green tea Nutrition 0.000 claims description 6
- 240000001810 Angelica gigas Species 0.000 claims description 5
- 235000018865 Angelica gigas Nutrition 0.000 claims description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 239000010440 gypsum Substances 0.000 claims description 3
- 229910052602 gypsum Inorganic materials 0.000 claims description 3
- 241000202807 Glycyrrhiza Species 0.000 claims 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims 2
- 244000020518 Carthamus tinctorius Species 0.000 claims 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims 1
- 238000003809 water extraction Methods 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 33
- 230000003340 mental effect Effects 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 6
- 239000006187 pill Substances 0.000 abstract description 5
- 230000035882 stress Effects 0.000 description 20
- 239000000203 mixture Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 235000013305 food Nutrition 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 239000002023 wood Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 4
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 4
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 4
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- 210000003016 hypothalamus Anatomy 0.000 description 4
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 102400000739 Corticotropin Human genes 0.000 description 3
- 101800000414 Corticotropin Proteins 0.000 description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 3
- 229960000258 corticotropin Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- 241000544270 Angelica acutiloba Species 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 241001105098 Angelica keiskei Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 244000004281 Eucalyptus maculata Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- YTZSBJLNMIQROD-SFBCHFHNSA-N Morroniside Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)O[C@@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YTZSBJLNMIQROD-SFBCHFHNSA-N 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 244000126002 Ziziphus vulgaris Species 0.000 description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000003443 bladder cell Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 239000011121 hardwood Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- -1 wine Chemical class 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- YTZSBJLNMIQROD-UHFFFAOYSA-N (4aS)-1c-beta-D-glucopyranosyloxy-6xi-hydroxy-8t-methyl-(4ar,8ac)-5,6,8,8a-tetrahydro-1H,4aH-pyrano[3,4-c]pyran-4-carboxylic acid methyl ester Natural products C12C(C)OC(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O YTZSBJLNMIQROD-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DSCFFEYYQKSRSV-UHFFFAOYSA-N 1L-O1-methyl-muco-inositol Natural products COC1C(O)C(O)C(O)C(O)C1O DSCFFEYYQKSRSV-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000271307 Aquilaria malaccensis Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- VJXUJFAZXQOXMJ-UHFFFAOYSA-N D-1-O-Methyl-muco-inositol Natural products CC12C(OC)(C)OC(C)(C)C2CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 VJXUJFAZXQOXMJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- DSCFFEYYQKSRSV-KLJZZCKASA-N D-pinitol Chemical compound CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-KLJZZCKASA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000011688 Generalised anxiety disease Diseases 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000243142 Porifera Species 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 244000015113 Salicornia europaea Species 0.000 description 1
- 235000003042 Salicornia europaea Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000037328 acute stress Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 229940125713 antianxiety drug Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 229940005530 anxiolytics Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000029364 generalized anxiety disease Diseases 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 150000004001 inositols Chemical class 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 230000004346 regulation of heart rate Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000009943 skeletal muscle blood flow Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 스트레스 완화 및 심신 안정에 도움을 줄 수 있는 건강 기능 식품에 관한 것으로서, 보다 구체적으로는, 녹용, 당귀, 산수유, 침향, 산조인, 원지, 복신, 석창포, 감초 및 스테비올라 배당체를 포함하는 환제 등의 제형으로 제조되는 건강 기능 식품에 관한 것이다. 본 발명의 건강 기능 식품은 현대인, 특히, 수험생의 스트레스 완화 및 심신 안정에 크게 도움을 주며, 부작용 없이 간편한 복용이 가능하므로 건강 기능 식품 산업상 매우 유용한 발명이다. The present invention relates to a health functional food that can help relieve stress and improve mental and physical stability. More specifically, the present invention relates to a health functional food, Pills and the like. The health functional food of the present invention is a very useful invention in the health functional foods industry because it is very helpful for modern people, especially for the examinees, to relieve stress and to ensure mental and physical stability and can be easily administered without side effects.
Description
본 발명은 스트레스 완화 및 심신 안정에 도움을 줄 수 있는 건강 기능 식품에 관한 것으로서, 보다 구체적으로는, 녹용, 당귀, 산수유, 침향, 산조인, 원지, 복신, 석창포, 감초 및 스테비올라 배당체를 포함하는 환제 등의 제형으로 제조되는 건강 기능 식품에 관한 것이다. The present invention relates to a health functional food that can help relieve stress and improve mental and physical stability. More specifically, the present invention relates to a health functional food, Pills and the like.
현대사회에서 복잡한 인간 관계와 눈부신 사회 변화에 따라 현대인들은 스트레스의 중압 하에서 생활하게 되었다. 특히, 수험생들은 공부량 과중과 시험 준비 과정에서의 어려움 등으로 상당한 스트레스에 노출되며, 이 때문에 스트레스가 주원인으로 알려진 우울증이 현대병의 하나로서 커다란 사회 문제가 되고 있다.In modern society, modern people have been living under the pressure of stress due to complicated human relations and dazzling social changes. Especially, the examinees are exposed to considerable stress due to the excessive amount of study and the difficulty in preparation for the examination. As a result, depression, which is known to be the main cause of stress, is becoming a big social problem as one of modern diseases.
이러한 스트레스를 유발하는 원인과 그로 인한 인체 내 생리적 변화는 다양하지만, 공통적으로 뇌하수체-부신계를 자극하여 스트레스 호르몬이 분비되고, 이러한 스트레스가 지속되면 인체의 기능이 저하되어 신경 과민, 두통, 소화 불량 등의 증상을 유발하며, 이것이 위십이지장궤양, 고혈압, 과민성대장염, 협심증 등의 2차 질병으로 발전된다. 특히, 인스턴트 및 합성 식품 첨가물을 많이 섭취하는 현대인들은 스트레스성 위장 장해로 고생하며, 또한 면역력이 저하되어 쉽게 피로해지고 감기에도 자주 걸리는 등의 스트레스의 위해를 느끼게 된다.The cause of the stress and the resulting physiological changes in the human body are various, but the stimulation of the pituitary-adrenal gland commonly stimulates the secretion of the stress hormone. When such stress is sustained, the function of the human body is deteriorated and the nervousness, headache, And it develops into a second disease such as gastroduodenal ulcer, hypertension, irritable colitis, and angina. In particular, modern people who consume a lot of instant and synthetic food additives suffer stress gastrointestinal disorder, and also suffer from stress such as being easily fatigued and often catching a cold due to decreased immunity.
스트레스와 관련된 신경 전달 물질 및 호르몬의 변화 기전을 간략하게 보면, 외부 자극 및 스트레스에 대해 체내의 시상 하부에서 신경 전달 물질 및 호르몬의 분비를 관장하는데, 시상 하부에서 중추신경계로의 시그널을 통해 도파민, 노르아드레날린, 세로토닌 등과 같은 신경 전달 물질이 각 신경 말단에서 유리되는 것이 조절되어 감정 상태, 심박동수, 혈압 및 골격근의 혈류 등과 같은 생리 활성이 조절되게 된다. 또한, HPA(hypothalamicpituitary-adrenal) axis system을 통해 혈액으로 호르몬이 분비되는데, 이는 시상하부에서 뇌하수체-부신으로 연결되는 호르몬의 circulation system이다. 만약, 인간이 외부 자극 또는 스트레스를 받게 되면, 체내의 시상 하부에서 CRF(corticotropin-releasing factor, 부신 피질 자극 호르몬 방출인자)를 분비하게 된다. 이후, 뇌하수체의 CRF와 특이적으로 결합하는 수용체에 상기 분비된 CRF가 결합하게 되면, ACTH(adrenocorticotropic hormone, 부신피질 자극 호르몬)이 분비된다. 상기 분비된 ACTH가 혈액 및 림프절을 통해 부신에 도착하게 되면, 피질에서 corticosterone과 같은 스테로이드 호르몬과 수질에서 catecholamine 류의 호르몬이 혈액으로 방출되어, 심박동수, 혈압 및 에너지 대사 등의 조절에 관여하게 되며, 또한 negative feedback regulation을 통하여 이들 인자들의 분비 조절이 이루어지고 있다.Stress-related changes in neurotransmitters and hormones can be summarized as follows: external stimuli and stress control the secretion of neurotransmitters and hormones in the body's hypothalamus; signals from the hypothalamus to the central nervous system, The release of neurotransmitters such as norepinephrine, noradrenaline, and serotonin is regulated at the distal end of each nerve to control physiological activities such as emotional state, heart rate, blood pressure, and skeletal muscle blood flow. In addition, hormones are secreted into the blood through the HPA (hypothalamic pituitary-adrenal) axis system, which is a circulation system of hormones that lead to the pituitary-adrenal gland from the hypothalamus. If a human is exposed to external stimuli or stress, it releases CRF (corticotropin-releasing factor) from the hypothalamus of the body. Thereafter, when the secreted CRF binds to a receptor that specifically binds to the pituitary gland CRF, an adrenocorticotropic hormone (ACTH) is secreted. When the secreted ACTH reaches the adrenal gland through the blood and lymph nodes, corticosterone-like steroid hormones and hormones of catecholamines are released into the blood in the corticosterone and water quality and are involved in the regulation of heart rate, blood pressure and energy metabolism , And negative regulation of the secretion of these factors.
이러한 스트레스가 과도하게 부과되고 있는 현대 사회에서 심신의 불안과 긴장을 완화하기 위한 제품이 절실히 요구되고 있으나, 심한 급성 스트레스나 심리적 충격으로 야기된 범불안 장애, 공황장애 등의 정신과적 치료를 위해 병원에서는 신경병과 우울증, 정신분열증 등의 치료에 정신안정제와 항우울제, 항불안제 등의 의약품이 이용되며, 이러한 증상의 개선에 효과가 있는 것으로 알려져 있다. 그러나, 항불안제, 항우울제, 진정제 등의 약물 이외에는 일반인들의 스트레스 완화에 쓰일 수 있는 제품은 없는 실정이다.In order to relieve mental and physical anxiety and tensions in the modern society where such stress is excessively imposed, products are urgently required. However, for psychiatric treatment such as generalized anxiety disorder or panic disorder caused by severe acute stress or psychological shock, Is used in the treatment of neuropathy, depression and schizophrenia, such as mental stabilizers, antidepressants, and anti-anxiety drugs are used to improve the symptoms are known to be effective. However, there are no products that can be used for stress relief of the general public except drugs such as anxiolytics, antidepressants and sedatives.
따라서, 일반인, 특히 수험생들을 대상으로 스트레스에 전반적인 효과가 있는 기능성 식품의 개발이 요구되고 있다. 현재 항스트레스 효과가 있는 건강식품이나 음료 등이 개발되어 판매되고 있긴 하지만, 음용에 거부감이 없고 기호성이 우수하며 평상시에 쉽게 접할 수 있는 개발이 요구되고 있다.Therefore, it is required to develop a functional food having an overall effect on stress for the general public, especially the examinees. Currently, health foods and beverages with antistress effect are developed and sold, but there is a need for development that has no resistance to drinking, excellent palatability, and easy accessibility to ordinary people.
본 발명은 상기와 같은 종래 기술의 현황을 개선시키기 위한 것으로서, 본 발명에서 해결하고자 하는 과제는 현대인, 특히, 수험생의 스트레스를 완화시키며, 심신을 안정시키는데 도움을 줄 수 있는 녹용을 함유하는 건강 기능 식품을 제공하고자 하는 것이다.DISCLOSURE OF THE INVENTION The present invention is to improve the state of the art as described above, and a problem to be solved by the present invention is to provide a health care product containing antler which can relieve stress of examinees, Food.
상기와 같은 과제를 해결하기 위하여, 본 발명은 녹용 100중량부에 대하여, 당귀 90~110중량부, 산수유 90~110중량부, 침향 5~8중량부, 산조인 15~25중량부, 원지 40~60중량부, 복신 40~60중량부, 석창포 40~60중량부, 감초 150~200중량부 및 스테비올라 배당체 50~60중량부를 포함하는 집중력 강화 및 스트레스 완화용 건강 기능 식품을 제공한다.In order to solve the above-mentioned problems, the present invention provides a method for preparing a green tea product, which comprises 90 to 110 parts by weight of Angelica keiskei koidz., 90 to 110 parts by weight of corn oil, 5 to 8 parts by weight of alumina, 15 to 25 parts by weight of acidophilus, And 40 to 60 parts by weight of boshi, 40 to 60 parts by weight of seokchangpo, 150 to 200 parts by weight of licorice and 50 to 60 parts by weight of steviola glycoside.
상기 건강 기능 식품에는 아이스플란트 30~50중량부를 더 포함할 수 있다.The health functional food may further contain 30 to 50 parts by weight of i-splint.
상기 건강 기능 식품에는 함초 20~50중량부를 더 포함할 수 있다.The health functional food may further contain 20 to 50 parts by weight of green tea.
상기 건강 기능 식품은 정제, 환제, 산제, 과립제, 캡슐제 및 현탁제로 이루어지는 군으로부터 선택되는 제형으로 제조되는 것이 바람직하다. It is preferable that the health functional food is produced by a formulation selected from the group consisting of tablets, pills, powders, granules, capsules and suspensions.
본 발명의 건강 기능 식품은 현대인, 특히, 스트레스 완화 및 심신 안정에 크게 도움을 주며, 부작용 없이 간편한 복용이 가능하므로 건강 기능 식품 산업상 매우 유용한 발명이다.The health functional food of the present invention is a very useful invention in the health functional food industry because it is very helpful for modern people, especially stress relaxation and mind and body stability, and can be easily taken without side effects.
이하, 본 발명의 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 발명자들은 현대인, 특히, 수험생이 갖는 스트레스, 심신 불안 등의 병리적 증상을 개선시키기 위한 천연물을 이용한 건강 기능 식품의 제조를 위한 연구를 거듭한 결과, 녹용을 주 재료로하여 제조된 본 발명의 건강 기능 식품이 상기 병리적 증상의 개선에 도움을 줄 수 있음을 확인하고 본 발명을 완성하였다.The inventors of the present invention have conducted studies for the preparation of health functional foods using natural products to improve pathological symptoms such as stress, mental and physical anxiety, etc., The present inventors have confirmed that the inventive health functional foods can contribute to the improvement of the above pathological symptoms and completed the present invention.
따라서, 본 발명은 녹용 100중량부에 대하여, 당귀 90~110중량부, 산수유 90~110중량부, 침향 5~8중량부, 산조인 15~25중량부, 원지 40~60중량부, 복신 40~60중량부, 석창포 40~60중량부, 감초 150~200중량부 및 스테비올라 배당체 50~60중량부를 포함하는 집중력 강화 및 스트레스 완화용 건강 기능 식품을 제공한다.Accordingly, the present invention provides a method for preparing a green tea composition comprising 90 to 110 parts by weight of Angelica keiskei koidz., 90 to 110 parts by weight of corn oil, 5 to 8 parts by weight of alumina, 15 to 25 parts by weight of acidophilus, 40 to 60 parts by weight, 60 to 60 parts by weight of Seokchangpo, 40 to 60 parts by weight of Seokchangpo, 150 to 200 parts by weight of Licorice and 50 to 60 parts by weight of steviolite glycoside.
본 발명의 건강 기능 식품의 성분으로서 녹용은 보정강장약(補精强壯藥)으로 사용된다. 사슴의 뿔은 늦봄에 저절로 떨어지는데, 곧 그 자리에 새로운 뿔이 자라며, 이 자라기 시작한 뿔을 녹용이라 한다. 부드러운 세모(細毛)로 덮여 있으며, 따뜻하고 혈관이 많이 들어 있으며 칼슘이 풍부하다. 한방에서는 이것을 귀한 약으로 쓰며, 가을이 되면 내부의 칼슘이 단단하게 각질화되는데, 이렇게 각질화된 뿔은 녹용보다 효능이 떨어지며 녹각이라고 한다. 본 발명에서는 각질화되지 않은 녹용을 사용하며, 추출물 형태로 제조하여 사용하는 것이 바람직하다. 바람직한 일 구체예로서, 녹용은 열수를 가하여 추출하여 제조되는 녹용 추출물을 사용할 수 있다.As a component of the health functional food of the present invention, antler antler is used as a correction medicine. The horns of the deer fall by themselves in late spring, soon new horns grow on the spot, and the horns that began to grow are called antler. It is covered with soft thin hair, is warm, contains a lot of blood vessels, and is rich in calcium. In one room, it is used as precious medicine. In fall, calcium inside is firmly keratinized. This cornified horn is less effective than antler, and it is called antler. In the present invention, it is preferable to use non-keratinized antler as a form of extract. As one preferred example, antler extract can be used as an antler extract prepared by extracting with hot water.
본 발명의 건강 기능 식품의 성분으로서 당귀는 한국에서는 산형과 참당귀(Angelica gigas Nakai), 중국에서는 산형과 중국당귀(Angelica sinensis (Oliv.) Diels)의 건조시킨 뿌리를 말한다. 일본에서는 산형과 왜당귀(Angelica acutiloba (Siebold. & Zucc.) Kitag.) 또는 홋카이당귀(Angelica acutiloba (Siebold. & Zucc.) Kitag. var. sugiyamae Hikino)의 뿌리를 말려서 사용한다. 위의 것들 중 어느 것을 사용하더라고 무방하나, 바람직하게는 참당귀를 사용하는 것이다. 당귀는 녹용 100중량부에 대하여 90~110중량부를 사용할 수 있으며, 바람직하게는 녹용과 동일한 함량으로 사용할 수 있다. 당귀는 건조 분말을 그대로 사용하거나, 열수 추출물의 형태로 가공하여 사용할 수 있다.As a constituent of the health functional food of the present invention, Angelica gigas Nakai is a dried root of Angelica gigas Nakai in Korea and Angelica sinensis (Oliv.) Diels in China. In Japan, the roots of Angelica acutiloba (Siebold. & Zucc.) Kitag. Or Angelica acutiloba (Siebold. & Zucc.) Kitag. Var. Sugiyamae Hikino) are dried and used. It is possible to use any of the above, but preferably to use true angelica. The angelica angelica can be used in an amount of 90 to 110 parts by weight, preferably about the same as antler for 100 parts by weight of antler. Angelica gigas can be used as it is or as a hot-water extract.
본 발명의 건강 기능 식품의 성분으로서 산수유는 층층나무과의 낙엽교목인 산수유나무의 열매이다. 타원형의 핵과(核果)로서 처음에는 녹색이었다가 8~10월에 붉게 익는다. 종자는 긴 타원형이며 능선이 있다. 약간의 단맛과 함께 떫고 강한 신맛이 난다. 10월 중순의 상강(霜降) 이후에 수확하는데, 육질과 씨앗을 분리하여 육질은 술과 차 및 한약의 재료로 사용한다. 과육(果肉)에는 코르닌(cornin), 모로니사이드(Morroniside), 로가닌(Loganin), 타닌(tannin), 사포닌(Saponin) 등의 배당체와 포도주산, 사과산, 주석산 등의 유기산이 함유되어 있고, 그밖에 비타민 A와 다량의 당(糖)도 포함되어 있다. 종자에는 팔미틱산, 올레인산, 리놀산 등이 함유되어 있다. 성분 중 코르닌은 부교감신경의 흥분작용이 있는 것으로 알려져 있다. 예로부터 한방에서는 과육을 약용하였는데, 동의보감 및 향약집성방 등에 의하면 강음(强陰), 신정(腎精)과 신기(腎氣) 보강, 수렴 등의 효능이 있는 것으로 기재되어 있다. 두통, 이명(耳鳴), 해수병, 해열, 월경과다 등에 약재로 쓰이며 식은땀, 야뇨증 등의 민간요법에도 사용되어, 차나 술로도 장복하며, 지한(止汗), 보음(補陰) 등의 효과가 우수한 약재이다. 산수유는 녹용 100중량부에 대하여 90~110중량부를 사용할 수 있으며, 바람직하게는 녹용과 동일한 함량으로 사용할 수 있다. 산수유는 건조 분말을 그대로 사용하거나, 열수 추출물의 형태로 가공하여 사용할 수 있다.As a component of the health functional food of the present invention, corn oil is a fruit of the persimmon tree which is a deciduous tree of the deep forest. Elliptical nuclei are green at first, but ripen reddish from October to October. Seeds are long oval and have ridges. It has a bitter sweetness and strong acidity. It is harvested after the frost fall in mid-October. The flesh is separated from the seeds and the meat is used as a material for sake, tea and Chinese medicine. The pulp contains the glycosides such as cornin, morroniside, loganin, tannin and saponin and organic acids such as wine, malic and tartaric acid. In addition, it contains vitamin A and a large amount of sugars. Seeds include palmitic acid, oleic acid, linoleic acid and the like. Among the components, cornin is known to have an excitatory action of parasympathetic nerves. It has been reported from the past that medicinal use of flesh was made in one room, and according to Dongbok-Bo and Sungbokgungbang, it is said that it has effects of strengthening, reinforcement of kidney and renal, and convergence. It is used for medicines such as headache, tinnitus, sea water bottle, fever, and menstrual hyperactivity. It is also used for folk remedies such as cold sweat and nocturnal enuresis. It is also used for tea and drink, and has effects such as perspiration, It is an excellent medicinal product. 90 to 110 parts by weight of corn oil may be used per 100 parts by weight of the antler, and may be used in the same amount as antler. Corn seed oil can be used by using dry powder as it is or by processing it in the form of hot water extract.
본 발명의 건강 기능 식품의 성분으로서 침향은 침향나무(Aquilaria agallocha Roxburgh)의 수지가 침착된 수간목이다. 침향은 침향나무에 천연적으로 분비된 수지가 침착하여 침향나무의 심재부위에 조직학적으로 단단한 덩어리 모양을 이루고 있는 부분이다. 침수향(沈水香)이라고도 한다. CP에는 백목향(白木香)의 수지를 함유한 목재로서 1년 중 아무 때나 채취하고 수지를 함유한 목재를 취하고 수지를 함유하지 않는 부분은 제거한 후 음건하는 것으로 기재되어 있다. 중국산 침향은 어느 정도 자란 백목향에 가로로 쐐기 등을 박음으로써 인위적으로 수지를 생성하게 하고 이것이 섞인 목재를 얻어 이를 침향이라 한 것이 대부분이다. 베트남 등지에서도 침향나무에 이와 같은 방법을 적용하고 있다. 그러나, 정품으로서의 침향은 침향나무에서 천연적으로 분비된 수지가 침착된 단단한 괴상의 목재를 가리키고 있다. 본 발명에서는 침향나무에서 천연적으로 분비된 수지가 침착된 정품 침향을 사용한다. 침향은 녹용 100중량부에 대하여 5~8중량부를 사용할 수 있으며, 바람직하게는 7중량부를 사용하는 것이다. 침향은 건조 분말을 그대로 사용하거나, 열수 추출물의 형태로 가공하여 사용할 수 있다.As a component of the health functional food of the present invention, the acne is an apical neck in which resin of Aquilaria agallocha Roxburgh is deposited. Dehydration is a part of the hardwood formed in the hardwood of the hardened wood by depositing naturally secreted resin on the hardened wood. It is also referred to as an immersion incense. CP is a wood containing white resin, which is taken at any time during the year and is said to take wood containing resin and remove the resin-free part and shade it. It is most common for the Chinese to grow an artificially created resin by putting a wedge or the like horizontally in a white box which has grown to some extent and to obtain the wood with this mixture. In Vietnam, the same method is applied to the wood. However, as a genuine product, it indicates a solid massive wood in which the naturally-secreted resin is deposited in the eucalyptus tree. In the present invention, a genuine plant growth in which a naturally-secreted resin is deposited in an eucalyptus tree is used. The propolis may be used in an amount of 5 to 8 parts by weight, preferably 7 parts by weight, based on 100 parts by weight of the antler. The dried powder can be used as it is or processed into the form of hot water extract.
본 발명의 건강 기능 식품의 성분으로서 산조인은 갈매나무과 식물인 멧대추나무(Zizyphus jujuba Mill. var. spinosus Bge.)의 여문 씨를 말린 것이다. 메대추나무(살맹이나무, 산대추나무)는 우리 나라 각지의 낮은 산이나 산기슭에서 자라며 특히 석회암 지대에 많다. 가을에 익은 열매를 따서 물에 담가 두어 열매살을 썩여 버리거나 벗겨 버리고 씨만 모아 햇볕에 말린다. 맛은 달고 시며 성질은 평하다. 심경(心經), 비경(脾經), 간경(肝經), 담경(膽經)에 작용한다. 심(心)과 간(肝), 담(膽)을 보하고 정신을 안정시키며, 비(脾)의 기능을 돕고 땀나는 것을 멎게 한다. 또한, 가슴이 답답한 것을 낫게 하고 뼈와 근육을 튼튼하게 한다. 물이나 알콜 우려낸 액체는 진정(鎭靜) 작용, 최면(催眠) 작용을 나타내며, 브롬나트륨과 협력 작용을 한다는 것이 밝혀졌다. 그 밖에 진통 작용, 진경(鎭驚) 작용, 혈압 강하 작용도 실험에서 밝혀졌다. 혈허(血虛)로 가슴이 답답하고 잠을 이루지 못하는 데, 잘 놀라고 가슴이 울렁거리는데, 땀이 잘 나는데, 관절통, 고혈압증, 신경쇠약 등에 쓴다. 산조인은 녹용 100중량부에 대하여 15~25중량부를 사용할 수 있으며, 바람직하게는 20~22중량부를 사용하는 것이다. 산조인은 건조 분말을 그대로 사용하거나, 열수 추출물의 형태로 가공하여 사용할 수 있다.As a component of the health functional food of the present invention, the acidophilus was dried from the lily of the Seedlings ( Zizyphus jujuba Mill. Var. Spinosus Bge.). Matured jujube trees grow in the low mountains of various parts of Korea and at the foot of mountains, especially in limestone areas. After the ripe fruits fall in autumn, they are soaked in water so that the fruit is decayed or stripped off, and only the seeds are dried in the sun. The taste is sweet and the quality is fair. It acts on the heart, the plexus, the liver, and the anus. It sees heart, liver, follicle, stabilizes the mind, helps the function of the spleen, and stops sweating. It also heals stiff chest and strengthens bones and muscles. Water and alcohol-derived liquids have been shown to work calmly, hypnotically, and cooperate with sodium bromide. In addition, the analgesic effect, the gyeonggyeong (鎭 驚 surprising) action, blood pressure lowering effect was also revealed in the experiment. I am frustrated with my blood pressure and can not sleep. I am surprised and chested. I sweat well. I use it for joint pain, hypertension, nervous breakdown. The acidophilus may be used in an amount of 15 to 25 parts by weight, preferably 20 to 22 parts by weight, based on 100 parts by weight of the antler. Sanjoin can be used either as it is or as a hot-water extract.
본 발명의 건강 기능 식품의 성분으로서 원지는 높이 약 30cm 정도로서, 뿌리는 굵고 길며, 끝에서 몇 개의 원줄기가 무더기로 나오고 거의 털이 없다. 잎은 어긋나고 줄 모양이며 길이 1.5~3cm이고 잎자루는 없다. 꽃은 7~8월에 자줏빛으로 피고 총상꽃차례에 드문드문 달린다. 꽃받침조각은 5개이고 뒤쪽과 밑의 것 2개는 줄 모양이며 양쪽 2개는 꽃잎같이 생기고 막질(膜質)이다. 꽃잎은 윗부분이 벌어지고 밑부분이 붙어 있으며 끝이 솔처럼 잘게 갈라진다. 열매는 삭과로서 납작하고 2개로 갈라지며 종자에는 털이 빽빽이 난다. 한방에서는 뿌리를 원지라고 하며 거담제, 강장제, 강정제 등으로 사용하는 것으로 알려져 있다. 원지는 녹용 100중량부에 대하여 40~60중량부를 사용할 수 있으며, 바람직하게는 45~50중량부를 사용하는 것이다. 원지는 건조 분말을 그대로 사용하거나, 열수 추출물의 형태로 가공하여 사용할 수 있다.As a component of the health functional food of the present invention, the base is about 30 cm in height, the roots are thick and long, and several main stems come out at the ends and have little hairs. Leaves are alternate phyllotaxis, 1.5 ~ 3cm long, with no petiole. Flowers blossom purple in July ~ August and run infrequently in the inflorescence. There are five calyxes, two on the back and the bottom on a line, and two on both sides like petals, and are membrane quality. The petal has an upper part, a lower part, and a tip that divides finely like a brush. The fruit is a capsule, flat, split into two pieces, and the seeds are dense with hair. In one room, it is said to be used as an expectorant, a tonic agent, and a gangjeje agent. The base material may be used in an amount of 40 to 60 parts by weight, preferably 45 to 50 parts by weight, per 100 parts by weight of the antler. The raw material can be used as it is or as a hot-water extract.
본 발명의 건강 기능 식품의 성분으로서 복신은 운령, 복토라고도 하며, 복령과 동일한 약재이나, 채취 과정에서 소나무 뿌리에서 기생하면서 뿌리가 복령을 관통하여 있는 것을 특히 복신이라 칭한다. 제조 과정에서 뿌리가 있는 부분을 정방형의 얇은 조각 모양으로 썰면 복신이 된다. 복령에 비해 마음을 안정시키고 심장을 강하게 하는 효능이 강하다. 복신은 녹용 100중량부에 대하여 40~60중량부를 사용할 수 있으며, 바람직하게는 45~50중량부를 사용하는 것이다. 복신은 건조 분말을 그대로 사용하거나, 열수 추출물의 형태로 가공하여 사용할 수 있다.As a component of the health functional food of the present invention, bexin is also referred to as "riton" or "botto", and it is called "bakkin" in that the roots penetrate the bamboo roots while being parasitized in the pine root in the extraction process. In the manufacturing process, the roots are cut into square pieces to form a double. Compared to the spirit of the spirit, the heart is strong and strong. 40 to 60 parts by weight, preferably 45 to 50 parts by weight per 100 parts by weight of antler grape can be used. Dextran can be used either as it is or as a hot-water extract.
본 발명의 건강 기능 식품의 성분으로서 석창포는 사철 푸른 잎을 가진 여러해살이풀이다. 뿌리줄기는 굵고 딱딱하며 많은 마디가 있으며 잔뿌리를 내어 바위틈과 같은 자리에 붙어살며, 잎은 뿌리줄기로부터 밑동이 서로 겹친 상태로 자라나는 특징이 있다. 꽃은 잎과 같은 생김새를 가진 꽃대의 중간부에 둥근 막대기 모양으로 뭉쳐 피며, 꽃이 뭉친 막대기의 길이는 5cm 안팎이고 빛깔은 노란빛을 띤 푸른색을 띤다. 석창포는 녹용 100중량부에 대하여 40~60중량부를 사용할 수 있으며, 바람직하게는 45~50중량부를 사용하는 것이다. 석창포는 건조 분말을 그대로 사용하거나, 열수 추출물의 형태로 가공하여 사용할 수 있다.As a component of the health functional food of the present invention, Sechangpo is a perennial plant having green leaves. The rootstock is thick and hard and has many nodes. It is attached to the same place as the rock gap by taking out the fin roots. The leaf has the feature that the roots grow from the root to the base. Flowers blend in the shape of a round stick in the middle of the flower-like frame with a leaf-like appearance. The length of the flower-shaped stick is about 5cm and the color is yellowish-blue. The silk cloth may be used in an amount of 40 to 60 parts by weight, preferably 45 to 50 parts by weight, per 100 parts by weight of the antler. The dried powder can be used as it is or as a hot-water extract.
본 발명의 건강 기능 식품의 성분으로서 감초는 모든 약의 독성을 조화시켜서 약효가 잘 나타나게 하며 장부의 한열과 사기를 다스리고 모든 혈맥의 소통을 잘 시키며 근육과 뼈를 튼튼히 한다. 약리작용은 해독작용, 간염, 두드러기, 피부염, 습진 등에 효과가 있다. 진해·거담, 근육이완, 이뇨작용, 항염작용이 있으며 소화성궤양을 억제하는 것으로 알려져 있다. 감초는 녹용 100중량부에 대하여 150~200중량부를 사용할 수 있으며, 바람직하게는 170~180중량부를 사용하는 것이다. 감초는 건조 분말을 그대로 사용하거나, 열수 추출물의 형태로 가공하여 사용할 수 있다.As a component of the health functional food of the present invention, licorice harmonizes the toxicity of all the drugs to make it appear more effective, regulates the fever and fragility of the book, improves communication of all blood vessels, and strengthens muscles and bones. Pharmacological action is effective in detoxification, hepatitis, urticaria, dermatitis, eczema. It is known to inhibit peptic ulcer, and it has Jinhae, genomic, muscle relaxation, diuretic action, anti-inflammatory action. The licorice may be used in an amount of 150-200 parts by weight, preferably 170-180 parts by weight, per 100 parts by weight of the antler. Licorice can be used as it is, or as a hot water extract.
본 발명의 건강 기능 식품의 성분으로서 스테비올라 배당체는 스테비아라는 원산지가 중남미의 열대 산간지방에서 자생하는 식물체 기원이다. 스테비아는 영하로 내려가는 곳에서는 뿌리마저 얼어 월동이 불가능한 식물이다. 잎과 줄기에는 단맛을 내는 스테비오사이드라는 성분이 들어 있는데 이것은 설탕의 당분보다 200~300배 높다. 우리나라에서는 월동을 위해 뿌리를 겨우내 얼지 않게 저장했다가 봄에 다시 심어야 하는 번거로움이 있다. 상기 스테비올라 배당체는 스테비오사이드를 일컫는 것으로서, 녹용 100중량부에 대하여 50~60중량부를 사용할 수 있으며, 바람직하게는 54~56중량부를 사용하는 것이다.As a component of the health functional food of the present invention, the steviola glycoside is a plant origin originating in the tropical mountainous region of Latin America where the origin of stevia is. Stevia is a plant that freezes its roots even when it goes down to zero. Leaves and stems contain stevioside, which is sweet, 200 to 300 times higher than sugar in sugar. In Korea, there is a hassle to reapply in the spring after freezing the roots for freezing. The steviolarglycoside refers to stevioside, which can be used in an amount of 50 to 60 parts by weight, preferably 54 to 56 parts by weight, per 100 parts by weight of antler.
본 발명의 건강 기능 식품에는 상기 설명된 각 성분 이외에도 추가적으로 아이스플란트 30~50중량부를 더 포함할 수 있다. 아이스플란트는 다육식물로서 발아율이 낮고 성장속도가 느리다. 원산지는 남아프리카의 나미브 사막이며 주요 분포 지역은 아프리카 남부, 동서부, 북부, 오스트레일리아 남서부, 아메리카의 서쪽 건조지역이다. 표면에 있는 투명한 결정체(블러더 세포)에는 이노시톨류, 베타카로틴과 같은 인체에 유용한 성분과 각종 미네랄을 함유하고 있다. 줄기와 잎의 블러더 세포는 얼음결정과 같은 모양을 가지고 있어 아이스플란트라 불린다. 특히, 아이스플란트에는 혈당치를 낮추는 피니톨(pinitol)과 중성지방을 억제하는 마이요이노시톨(myoinosito)을 많이 함유하고 있기 때문에 잎과 줄기를 생식하거나 즙액으로 사용하면 당뇨병 환자에 적합한 힐링 푸드(Healing food vegetable)로서 알려져 있다. The health functional food of the present invention may further comprise 30 to 50 parts by weight of an iced sponge in addition to the components described above. Isplant is a succulent plant with low germination rate and slow growth rate. Origin is Namib Desert, South Africa. The main distribution areas are South Africa, Eastern and Western, Northwest, Southwest Australia, and the arid western part of the Americas. Transparent crystals (bladder cells) on the surface contain a variety of minerals and components useful for the human body, such as inositols and beta-carotene. Bladder cells in the stem and leaf have the same shape as ice crystals and are called the iced spleen. Especially, since it contains a lot of pinitol which lowers the blood sugar level and myoinositol which suppresses the neutral fat, the leaf and stem are used for the reproduction or the juice, and the healing food suitable for diabetics vegetable.
본 발명의 건강 기능 식품에는 상기 설명된 각 성분 이외에도 추가적으로 함초 20~50중량부를 더 포함할 수 있다. 함초는 퉁퉁마디(Salicornia europaea)로도 불리우며, 한해살이풀로서 줄기의 높이는 15~35㎝ 가량으로, 줄기는 마디가 많고, 가지는 마주나며 원기둥 모양으로 살이 많은데, 처음에는 짙은 녹색이었다가 가을이 되면 홍적색으로 변한다. 잎은 없으며 8~9월경이 되면 녹색꽃이 수상 꽃차례를 이루면서 가지 끝에 달린다. 함초에는 콜린(Choline)과 비테인(Betain), 식이섬유 및 미네랄 등이 포함돼 간의 독소 해소와 지방간 치유, 면역기능 증강 등에 효능이 있는 것으로 알려져 있다.The health functional food of the present invention may further contain 20 to 50 parts by weight of green tea, in addition to the above-described components. It is also known as Salicornia europaea. It is an annual plant with a height of 15 ~ 35㎝. Its stem has many nodes, and its stem is round and cylindrical. It is dark green at first and reddish red . There is no leaf, and from August to September, a green flower forms an inflorescence and runs on the end of the branch. Chlorine, Betaine, dietary fibers and minerals are known to be effective in removing toxins from the liver, healing fatty liver, and enhancing immune function.
상기 본 발명의 건강 기능 식품의 각 성분으로 서로 조합되어 작용함으로써 본 발명이 목적하는 스트레스 완화, 및 심신 안정의 효과를 얻을 수 있다. By acting in combination with each component of the health functional food of the present invention, the desired stress relief and mental and physical stability effects of the present invention can be obtained.
바람직한 구체예로서, 본 발명의 건강 기능 식품은 스트레스, 불안, 불면, 소화 불량, 두통, 편두통, 신경증, 적응장애, 신경쇠약 등의 질환의 개선에 효과적으로 사용될 수 있다.As a preferable example, the health functional food of the present invention can be effectively used for the improvement of diseases such as stress, anxiety, insomnia, indigestion, headache, migraine, neurosis, adaptation disorder, and nervous breakdown.
상기 건강 기능 식품은 정제, 환제, 산제, 과립제, 캡슐제 또는 현탁제로 제조될 수 있다. 본 발명의 건강 기능 식품에는 추가적으로 담체, 부형제 또는 희석제 등이 더 포함될 수 있으며, 포함될 수 있는 적합한 담체, 부형제 또는 희석제의 예로는 락토오스, 덱스트로오스, 수크로오스, 솔비톨, 만니톨, 자일리톨, 에리쓰리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로스, 메틸 셀룰로스, 비정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸하이드록시벤조에이트, 프로필하이드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유 등을 들 수 있다. 또한, 본 발명의 건강 기능 식품은 충전제, 항응집제, 윤활제, 습윤제, 향료, 유화제, 방부제 등을 추가로 더 포함할 수도 있다.The health functional food may be prepared as tablets, pills, powders, granules, capsules or suspensions. The health functional food of the present invention may further contain a carrier, an excipient or a diluent, and examples of suitable carriers, excipients or diluents that may be included include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, But are not limited to, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methylcellulose, amorphous cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, And mineral oil. The health functional food of the present invention may further include a filler, an anti-coagulant, a lubricant, a wetting agent, a flavoring agent, an emulsifier, an antiseptic, and the like.
본 발명의 상기 설명된 성분들은 일반 식품 조성물로서 적용될 수 있음은 당연하다. It is to be understood that the above-described ingredients of the present invention can be applied as a general food composition.
바람직한 구체예로서, 본 발명의 상기 설명된 성분들을 포함하는 식품 조성물로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강 보조 식품류 등이 있고, 분말, 과립, 정제, 캡슐 또는 음료인 형태로 사용할 수 있다.As a preferable example, the food composition containing the above-described ingredients of the present invention may be, for example, various foods, beverages, gums, tea, a vitamin complex, a health supplement food and the like, and may be a powder, a granule, Or as a beverage.
본 발명의 상기 설명된 성분들은 일반적으로 전체 식품 조성물의 0.01 내지 50중량%로 가할 수 있으며, 건강 음료 조성물은 100ml를 기준으로 0.02 내지 30g, 바람직하게는 0.3 내지 10g의 비율로 가할 수 있다.The above-described ingredients of the present invention can generally be added in an amount of 0.01 to 50% by weight of the total food composition, and the health beverage composition can be added in a proportion of 0.02 to 30 g, preferably 0.3 to 10 g, based on 100 ml.
본 발명의 식품 조성물은 지시된 비율로 필수 성분으로서 상기 설명된 성분들을 함유하는 것 외에 식품학적으로 허용 가능한 식품 보조 첨가제, 예컨대, 천연 탄수화물 및 다양한 향미제 등을 추가 성분으로서 함유할 수 있다. The food composition of the present invention may contain, in addition to containing the ingredients described above as essential ingredients in the indicated ratios, a food-acceptable food-aid additive, such as natural carbohydrates and various flavors, as an additional ingredient.
상기 천연 탄수화물의 예로는 포도당, 과당 등의 단당류, 말토오스, 수크로오스 등의 이당류 및 덱스트린, 시클로덱스트린 등의 다당류와 같은 통상적인 당 및 자일리톨, 소르비톨, 에리쓰리톨 등의 당알코올이 있다. Examples of the natural carbohydrate include sugar sugars such as glucose, monosaccharides such as fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol.
상기 향미제로는 타우마틴, 레바우디오시드 A 또는 글리시르히진과 같은 스테비아 등의 천연 향미제 및 사카린, 아스파르탐 등의 합성 향미제를 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 식품 조성물 100ml당 일반적으로 약 1 내지 20g, 바람직하게는 약 5 내지 12g을 사용한다. 상기 외에 본 발명의 식품 조성물은 여러 가지 영양제, 비타민, 광물, 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 식품 조성물은 천연 과일 주스 및 과일 주스 음료 및 야채 음료 등의 제조를 위한 과육을 함유할 수도 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 본 발명의 상기 설명된 성분들의 혼합물 100중량부 당 0.01 내지 약 20중량부의 범위에서 선택되는 것이 일반적이다.Examples of the flavoring agents include natural flavoring agents such as tautatin, rebaudioside A and stiglycerin such as glycyrrhizin, and synthetic flavoring agents such as saccharin and aspartame. The ratio of the natural carbohydrate is generally about 1 to 20 g, preferably about 5 to 12 g per 100 ml of the food composition of the present invention. In addition to the above, the food composition of the present invention may further contain various additives such as flavorings such as various nutrients, vitamins, minerals, synthetic flavors and natural flavors, colorants and aging agents, pectic acid and its salts, alginic acid and its salts, , pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like. In addition, the food composition of the present invention may contain flesh for the production of natural fruit juice and fruit juice drinks and vegetable drinks and the like. These components may be used independently or in combination. The ratio of such additives is generally selected in the range of 0.01 to about 20 parts by weight per 100 parts by weight of the mixture of the above-described components of the present invention.
이하에서는, 구체적인 실시예를 통하여 본 발명을 더욱 상세하게 설명한다. 하기 실시예는 본 발명의 바람직한 일 구체예를 기재한 것이며, 하기 실시예에 기재된 사항에 의하여 본 발명의 권리범위가 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to specific examples. The following examples illustrate one preferred embodiment of the present invention and are not intended to limit the scope of the present invention by the matters described in the following examples.
[실시예][Example]
실시예 1Example 1
녹용 추출물 건조 분말 140g, 당귀 추출물 건조 분말 140g, 산수유 추출물 건조 분말 140g, 침향 추출물 건조 분말 10g, 산조인 추출물 건조 분말 30g, 원지 추출물 건조 분말 70g, 복신 추출물 건조 분말 70g, 석창포 추출물 건조 분말 70g, 감초 추출물 건조 분말 250g 및 스테비올라 배당체 80g을 혼합하여 본 발명의 건강 기능 식품 성분을 포함하는 직경 0.5cm의 환을 제조하였다.140g of antler extract, 140g of dry powder of Angelica gigas Nakai extract, 140g of dried powder of corn oil extract, 140g of dried powder of perilla seed extract, 10g of dried powder of acid extract, 30g of dried extract powder of oriental extract, 70g of dried powder of ginseng extract, 70g of dried powder of ginseng extract, 250 g of dry powder and 80 g of steviola gypsum were mixed to prepare a ring having a diameter of 0.5 cm containing the health functional food ingredient of the present invention.
실시예 2Example 2
아이스플란트 추출물 건조 분말 70g을 더 첨가한 것을 제외하고는 실시예 1과 동일한 방법으로 환을 제조하였다.A ring was prepared in the same manner as in Example 1, except that 70 g of dry powder of an iced sultanate extract was further added.
실시예 3Example 3
함초 추출물 건조 분말 60g을 더 첨가한 것을 제외하고는 실시예 2와 동일한 방법으로 환을 제조하였다.A ring was prepared in the same manner as in Example 2 except that 60 g of dried powder of green tea extract was further added.
비교예Comparative Example
감초 추출물 건조 분말 250g 및 스테비올라 배당체 80g을 혼합하여 직경 0.5cm의 환을 제조하였다.250 g of dried powder of licorice extract and 80 g of steviola gypsum were mixed to prepare a ring having a diameter of 0.5 cm.
실험예Experimental Example
상기 실시예 1 내지 실시예 3 및 비교예에서 제조된 환을 수험생 50인을 대상으로 1일 2회씩 회당 5알씩 3개월 간 복용하게 하고 아래 각 항목에 따라 평가하였다. 평가 결과는 1~5점(1점: 악화됨, 3점: 변화 없음, 5점: 개선됨)으로 나타내었다. Fifty individuals from the above-mentioned Examples 1 to 3 and Comparative Example were administered to 50 examinees twice a day for 5 months each for 3 months, and evaluated according to the following items. The evaluation results were expressed as 1 ~ 5 points (1 point: worse, 3 points: no change, 5 points: improved).
평가 항목
Evaluation items
실시예 1
Example 1
실시예 2
Example 2
실시예 3
Example 3
비교예
Comparative Example
상기 표 1에 나타난 바와 같이, 본 발명의 실시예 1 내지 실시예 3은 환제는 프라시보로서 사용된 비교예에 비하여 스트레스를 줄여주었으며, 심신 안정 및 숙면에 효과가 있음을 확인할 수 있었다.As shown in Table 1, Examples 1 to 3 of the present invention showed that the pill was reduced in stress as compared with the Comparative Example used as Prasibo, and that it was effective for mental and physical stability and good sleep.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160126959A KR101884330B1 (en) | 2016-09-30 | 2016-09-30 | Helth functional food comprising the extract of deer antlers having the effect on stress and calmness |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160126959A KR101884330B1 (en) | 2016-09-30 | 2016-09-30 | Helth functional food comprising the extract of deer antlers having the effect on stress and calmness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20180036401A KR20180036401A (en) | 2018-04-09 |
| KR101884330B1 true KR101884330B1 (en) | 2018-08-01 |
Family
ID=61978355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020160126959A KR101884330B1 (en) | 2016-09-30 | 2016-09-30 | Helth functional food comprising the extract of deer antlers having the effect on stress and calmness |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101884330B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101982811B1 (en) | 2018-09-20 | 2019-05-29 | 주식회사 비앤에이치랩 | Composition for relieving stress |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101953366B1 (en) * | 2018-12-26 | 2019-02-28 | 정종문 | Functional Health Foods Comprising Aloeswood for Promoting Memory and Perceptivity and Preparation Methods Thereof |
-
2016
- 2016-09-30 KR KR1020160126959A patent/KR101884330B1/en active IP Right Grant
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101982811B1 (en) | 2018-09-20 | 2019-05-29 | 주식회사 비앤에이치랩 | Composition for relieving stress |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20180036401A (en) | 2018-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5864252B2 (en) | Medicinal plant extract using smoked product and skin external preparation composition containing the same | |
| CN105815717A (en) | Vaccinium bracteatum thunb.fruit flavor red ginseng fruit jam | |
| KR101947786B1 (en) | Food Composition for Stress Relaxation, Fatigue Recovery or Athletic Performance Enhancement Comprising Extract of herb | |
| KR20200060598A (en) | Ssanghwa tea and its manufacturing method | |
| CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
| CN103125710A (en) | Bazhen tea for women | |
| KR101751211B1 (en) | Composition for improving sexual function, Functional food Composition for improving sexual function comprising of the same and Manufacturing method thereof | |
| CN105296313A (en) | Compound and fermented ginseng health drink and production process thereof | |
| KR101884330B1 (en) | Helth functional food comprising the extract of deer antlers having the effect on stress and calmness | |
| CN109430612A (en) | A kind of date-wolfberry fruit juice and its production method | |
| KR20090002854A (en) | Composition for stimulating/inducing hair growth andprocess for their preparation | |
| KR20130137066A (en) | Manufacturing process of makgeolli mixed with winter melon | |
| CN105062773A (en) | Compound fermented health drink containing maca and production process of health drink | |
| KR20180089696A (en) | Removing Method for Residual Agricultural Chemicals of Natural Plant Extracts | |
| CN106010865A (en) | Muntingia colabura flavor fructus lonicera standishii wine and brewing method thereof | |
| KR20110131143A (en) | Health noodle manufacturing method containing audi and herbal composition and health noodle manufactured therefrom | |
| KR102491108B1 (en) | Manufacturing process for rice syrup by using red ginseng and red ginseng rice syrup thereby the same that | |
| KR20100016684A (en) | Tea making method | |
| CN103798399A (en) | Soybean milk with effects of eliminating indigestion and refreshing and preparation method thereof | |
| KR20090075090A (en) | Blood pressure therapeutic agent for chinese medicine and manufacture method thereof | |
| CN103436416B (en) | Anti-hypertension healthcare wine and production method thereof | |
| CN106578813A (en) | Formula and making method of spina date seed-containing solid beverage | |
| CN106520491A (en) | Wild red fruit and dendrobium mixed flavor fruit wine | |
| CN105054146A (en) | Making method of sour soup | |
| KR101720927B1 (en) | A process for the preparation of functional beverage comprising balloon flower root and bamboo extracts and the functional beverages prepared therefrom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| AMND | Amendment | ||
| E601 | Decision to refuse application | ||
| AMND | Amendment | ||
| X701 | Decision to grant (after re-examination) | ||
| GRNT | Written decision to grant |